Quality, quantity and the question of politics – EAPM Lung Cancer Screening event, 10 December
Welcome, health colleagues, to the latest update from the European Alliance for Personalised Medicine (EAPM) – November and December will see a renewed focus, both from EAPM and the EU institutions, to issues of cancer mortality and treatment, which have not gone away, pandemic or no pandemic. The EU Beating Cancer Plan is taking shape from 10 December and, ahead of that, EAPM is focusing on its own approach to the disease based on our multi-stakeholder engagement and the role of diagnostics during the month ahead. In addition, the EAPM Newsletter will be available from tomorrow (30 October), writes EAPM Executive Director Denis Horgan.
Beating cancer – the road to success
While the Europe’s Beating Cancer Plan aims to reduce the cancer burden for patients, their families and health systems. It is set to address cancer-related inequalities between and within member states with actions to support, co-ordinate and complement member states’ efforts.
In terms of its implementation, EAPM have advocated that the European Beating Cancer Plan needs to be realistic and measurable, so it should come with a dashboard of indicators that can be monitored, and which would enable evaluation to monitor the effectiveness of this plan.
In cancer, the important role of high-quality diagnostics as well as pathological expertise is not yet broadly recognized. If you have a symptom or a screening test result that suggests cancer, your doctor must find out whether it is due to cancer or some other cause. The doctor may start by asking about your personal and family medical history and do a physical exam. The doctor also may order lab tests, imaging tests (scans), or other tests or procedures. You may also need a biopsy, which is often the only way to tell for sure if you have cancer. To identify the right treatment, early diagnosis is essential.
As such for the area of lung cancer, a more targeted approach to screening is warranted and appropriate stratification should be considered.
Taking into account the shortage of expertise within countries, the role of cross-country molecular tumour board will have an important role. A governance framework for the way that data can be shared between countries will be essentials here.
EAPM has brought these and other issues before MEPs over recent months since our successful seminar series at the European Society of Medical Congress during the recent EU Presidency conference.
Commission plan receives support from cancer committee for treatment
With more than 40% of cancers preventable, the EU can do more to tackle the disease, one of the leading causes of mortality in Europe, according to the European Parliament’s cancer committee. “By pooling all our talents, knowledge and resources, we can truly join all our forces in the fight against cancer.” So claimed Manfred Weber during the 2019 elections, paving the way for a special committee in the fight against cancer. Today this committee is a reality. This fight will be a priority for many in the coming years. Commission President Ursula von der Leyen announced a European Plan to fight Cancer in her political guidelines and Health Commissioner Stella Kyriakides has shown her ambitions in presenting the EU Beating Cancer Plan in the Parliament, which will be finalised by the end of 2020. This special committee is needed now more than ever.
By pooling resources and expertise, a comprehensive European cancer masterplan can be created, acting as a catalyst for thorough and innovative cancer care and research, which should be focused on prevention, specialized care and treatment that puts the patients at its heart, as well as a zero-pollution environment. Prevention is key in the fight against cancer, and cancer treatment requires the correct specialized therapy. As early as 2003, the Council issued recommendations to roll out cancer screening programmes for some of the more prevalent cancers, but their implementation is far from complete. Increased investment through programmes such as Horizon 2020, as well as knowledge-sharing bodies like the European Reference Networks, are invaluable policy tools that the EU has at its disposal in the Beating Cancer Plan.
EU needs more power on health policy, says Commission’s Irish rep
The European Commission’s representative to Ireland Gerry Kiely, speaking on Wednesday (28 October), told the Irish parliament that the EU’s contribution to fighting COVID-19 was initially limited because member states wanted it so. But the member states must collectively manage a long and difficult shared crisis, he added, going on to say that surveillance across the EU, and indeed within Member States, is still slow, inconsistent and patchy. The ECDC can provide common methodologies for information gathering, but it has no way to ensure that member states provide information in the prescribed manner.
To make information flows more integrated and useful, the EU could direct resources and create obligations for member states to improve surveillance and reporting. As far as the ECDC is concerned, it has very little power, let alone budget, to respond in a way comparable to its US counterpart. The Commission is set to announce just how this agency’s role will change in two weeks’ time.
European leaders are set to meet online today to discuss COVID-19 co-ordination, following the 15 October European Council. “Even though member states are better prepared and more co-ordinated than in the early months of the pandemic, citizens, families and communities across Europe continue to face an unprecedented risk to their health and well-being,” said a Commission statement.
UK under pressure as COVID-19 epidemic doubles every nine days
The British government is under pressure to develop a national strategy to combat a surge of COVID-19 cases and “rescue Christmas” as scientists warn that the number of people hospitalized with the disease in the UK could almost triple by the end of next month unless something more is done now. Mark Walport, a former chief scientific officer, said Britain only needs to look across the English Channel to see what’s coming. Britain’s current measures are similar to those in France and Spain, where authorities are struggling to control the virus and daily cases have already far outstripped those in the UK. “With our current measures… there’s little evidence that there is as much social distancing as there was when we clamped down on the first wave and so we know that the risk is significant that cases will continue to grow,” Walport told the BBC. It is “not unrealistic” that 25,000 people in the UK could be hospitalized by the end of November—up from about 9,000 now, he said.
Germany shuts up shop
On Wednesday (28 October), Chancellor Angela Merkel and Germany’s state premiers agreed to close bars, restaurants, gyms, pools, cinemas and other non-essential businesses nationwide for the month of November. “We have to act now to avoid an acute national emergency,” Merkel said. “The experts told us we have to reduce the number of contacts by 75% — that’s a lot.”
France est fermé
President Emmanuel Macron has announced his own national lockdown starting Friday (30 October), with restaurants and bars to be closed but schools, public services and some factories remaining open. Unlike in the first lockdown, visits to nursing homes will be allowed.
Von der Leyen: EU could vaccinate 700M people against coronavirus
The EU could vaccinate 700 million people with large supplies of vaccines due to begin in April 2021, Commission President Ursula von der Leyen has said today (29 October). Von der Leyen also reiterated her call for the harmonization of countries’ vaccination plans. “There are many issues to be considered for an effective vaccine deployment,” she said, pointing to questions around infrastructure, such as cold chains.
Health data space en route
The Commission is pushing forward plans for a European health data space, with an interim report from recent expert workshops to be published before the end of 2020, said Health Commissioner Stella Kyriakides on Monday (26 October) during the World Health Summit. However, important questions remain about public trust and whether people will be willing to share their data on a pan-EU platform.
And that is everything from EAPM for now – do stay safe and well, look out for the EAPM Newsletter from tomorrow, and have a splendid afternoon.